Introduction
Although the pathophysiology of rheumatoid arthritis (RA) is not fully understood, certain mediators have been shown to be important in the development of inflammation. The role of prostaglandins (PGs), metabolites of arachidonic acid (AA) via the action of cyclo-oxygenase (CO), is well established. Recently, leukotrienes (LTs), 5 13 An ex vivo study of the effects of tenidap on FR activity in patients with RA is currently underway in a double-blind study. The correlation between tenidap's effects on RA activity, and the production and removal of FRs will be assessed. It is hoped that results from this study will improve our understanding of the pathophysiological role of free radicals in rheumatoid arthritis.
